Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebocontrolled dose-ranging study - Denys, P; Le Normand, L; Ghout, I (Eur Urol, 2012)
et al.